MarketCap
Facebook
X
TelegramQuartalsbericht 2026-Q1
hinzugefügt 07.05.2026
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Diagnostik & Forschung |
Börse |
NYSE AMERICAN |
Anteile |
41.7 M |
Marktkapitalisierung |
$ 293 M |
EBITDA (LTM) |
$ -81.9 M |
P/E (LTM) |
-4.54 |
P/S (LTM) |
6.84 |
EPS (LTM) |
-1.18 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 19.5 | 7.5 % | $ 600 M | Nasdaq Global Market | USA |
 |
Celcuity
CELC
|
$ 92.47 | 3.96 % | $ 4.32 B | Nasdaq Global Select Market | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Co-Diagnostics
CODX
|
$ 5.76 | 11.41 % | $ 7.66 M | Nasdaq Capital Market | USA |
 |
Guardant Health
GH
|
$ 133.06 | 4.75 % | $ 16.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Castle Biosciences
CSTL
|
$ 21.6 | 5.93 % | $ 626 M | Nasdaq Global Market,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
CareDx, Inc
CDNA
|
$ 23.12 | 3.63 % | $ 1.23 B | Nasdaq Global Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 152.8 | 6.18 % | $ 12 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Interpace Biosciences
IDXG
|
$ 1.79 | 2.29 % | $ 7.92 M | Nasdaq Global Select Market | USA |
 |
Illumina
ILMN
|
$ 168.06 | -1.68 % | $ 26 B | Nasdaq Global Select Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 102.82 | 2.56 % | $ 6.94 B | Nasdaq Global Select Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 185.79 | 3.29 % | $ 9.21 B | NYSE,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 180.48 | 0.95 % | $ 24.3 B | NYSE,SPB |  Schweiz |
 |
Medpace Holdings
MEDP
|
$ 458.69 | 1.75 % | $ 13.2 B | Nasdaq Global Select Market,SPB | USA |
 |
NeoGenomics
NEO
|
$ 11.31 | 11.54 % | $ 1.45 B | Nasdaq Global Select Market,SPB | USA |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
Natera
NTRA
|
$ 222.1 | 4.84 % | $ 30.4 B | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 19.75 | 3.73 % | $ 442 M | Nasdaq Global Select Market | USA |
 |
Myriad Genetics
MYGN
|
$ 4.69 | 6.59 % | $ 434 M | Nasdaq Global Select Market,SPB | USA |
 |
Personalis
PSNL
|
$ 12.1 | 12.24 % | $ 1.08 B | Nasdaq Global Select Market | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 25.99 | 2.48 % | $ 24.6 B | NYSE |  Niderland |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | Niderland |
 |
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | USA |
 |
Biomerica
BMRA
|
$ 2.15 | 1.9 % | $ 4.94 M | Nasdaq Capital Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 260.97 | 0.79 % | $ 21.7 B | NYSE,SPB | USA |
 |
Twist Bioscience Corporation
TWST
|
$ 73.93 | 2.21 % | $ 4.42 B | Nasdaq Global Select Market,SPB | USA |
 |
Thermo Fisher Scientific
TMO
|
$ 482.03 | 1.7 % | $ 182 B | NYSE,SPB | USA |
 |
Trinity Biotech plc
TRIB
|
$ 0.68 | -2.4 % | $ 244 M | Nasdaq Global Select Market | Irlanda |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Neogen Corporation
NEOG
|
$ 9.12 | 3.52 % | $ 1.98 B | Nasdaq Global Select Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 196.12 | 1.27 % | $ 21.8 B | NYSE,SPB | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
Waters Corporation
WAT
|
$ 376.47 | -0.87 % | $ 22.4 B | NYSE,SPB | USA |